Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site
American Journal of Translational Research · 2026 · 18 (6) · 5399-5410
DOI: 10.62347/rcgz7850 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Shuyan Ru und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Huishan 3rd People's Hospital of Wuxi City Wuxi 214183, Jiangsu, China. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Huishan 3rd People's Hospital of Wuxi City Wuxi 214183, Jiangsu, China.
- Department of Intensive Care Medicine, Wuxi People's Hospital, Affiliated to Nanjing Medical University Wuxi 214023, Jiangsu, China.
Zitieren
APA
Ru, S., Ji, F., Yang, G., & Xv, H. (2026). Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site. American Journal of Translational Research, 18(6), 5399-5410. https://doi.org/10.62347/rcgz7850
Vancouver
Ru S, Ji F, Yang G, Xv H. Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site. American Journal of Translational Research. 2026;18(6):5399-5410. doi:10.62347/rcgz7850
BibTeX
@article{Ru2026,
author = {Ru, Shuyan and Ji, Fuqi and Yang, Gan and Xv, Hongyang},
title = {Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {6},
pages = {5399--5410},
doi = {10.62347/rcgz7850}
}
EUVIMED